Diabetes Metab Syndrome
Simply put, its the fact that its currently illegal to obtain as well as to use for clinical studies, meaning it cannot be studied for its benefits or side effects
CrossRef Insight into continuous glucose monitoring: from medical basics to commercialized devices Ayman Chmayssem, Magorzata Nadolska, Emily Tubbs, Kamila Sadowska, Pankaj Vadgma, Isao Shitanda, Seiya Tsujimura, Youssef Lattach, Martin Peacock, Sophie Tingry, Stphane Marinesco, Pascal Mailley, Sandrine Lablanche, Pierre Yves Benhamou, Abdelkader Zeb Microchimica Acta.2023;[Epub] CrossRef Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial Shuo Zhang, Chuanyan Zhang, Jingxian Chen, Feiying Deng, Zezhen Wu, Dan Zhu, Fengwu Chen, Yale Duan, Yue Zhao, Kaijian Hou Frontiers in Pharmacology.2023;[Epub] CrossRef Impact of continuous glucose monitoring on glycemic control and its derived metrics in type 1 diabetes: a longitudinal study So Hyun Cho, Seohyun Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Gyuri Kim, Jae Hyeon Kim Frontiers in Endocrinology.2023;[Epub] CrossRef Association Between Continuous Glucose Monitoring-Derived Glycemia Risk Index and Albuminuria in Type 2 Diabetes Jee Hee Yoo, Ji Yoon Kim, Jae Hyeon Kim Diabetes Technology & Therapeutics.2023
As fasting increases ketone production with a concomitant increase in CYP2E1 activity, this in turn increases the production of NAPQI and decreases amino acid substrates for GSH production
